XML 66 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
SHAREHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2012
SHAREHOLDERS' EQUITY [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 11:-
SHAREHOLDERS' EQUITY

 
a.
Ordinary share:

The Ordinary shares entitle their holders to voting rights, the right to receive cash dividend and the right to a share in excess assets upon liquidation of the Company. In January 6, 2011 the shareholders resolved to increase the authorized share capital of the Company to 40,000,000 Ordinary shares with a nominal value of NIS 0.01 each.

 
b.
Share option plans:
In 2003, the Company adopted a share option plan ("the 2003 Plan"). Under the 2003 Plan, employees, officers and non-employees may be granted options to acquire Ordinary shares. Pursuant to the 2003 Plan, the Company has reserved for issuance a total of 4,368,000 Ordinary shares. As of December 31, 2012, 1,005,173 options were still available for future grant under the 2003 Plan.
Options granted under the 2003 Plan vested over three years from the grant date. The options expire no later than five years from the date of grant.
A summary of the activity in the share options granted to employees, non-employees and directors for the year ended December 31, 2012 and related information is as follows:
         
Weighted average
       
   
Number of options
   
Exercise price
   
Remaining contractual
term
(in Years)
   
Aggregate intrinsic
value
 
                         
Outstanding at January 1, 2012
    1,776,072     $ 5.87       3.39     $ 113  
Granted
    1,060,501     $ 6.19                  
Exercised *)
    (209,067 )   $ 4.41                  
Cancelled
    (221,206 )   $ 6.12                  
Forfeited
    (82,666 )   $ 7.09                  
                                 
Outstanding at December 31, 2012 **)
    2,323,634     $ 6.09       3.38     $ 6,971  
                                 
Exercisable at December 31, 2012 ***)
    694,005     $ 5.72       2.31     $ 2,278  
 
*)
During 2012, 25,000 share options were exercised in consideration for cash received in an amount of $ 76 and 184,067 share options were exercised under net-share settlement.
 
**)
Represents intrinsic value of 1,930,300 outstanding options that are in-the-money as of December 31, 2012. The remaining 393,334 outstanding options are out of the money as of December 31, 2012, and their intrinsic value was considered as zero.


 
***)
Represents intrinsic value of 650,672 exercisable options that are in-the-money as of December 31, 2012. The remaining 43,333 outstanding options are out of the money as of December 31, 2012, and their intrinsic value was considered as zero.
The weighted-average grant-date fair value of options granted during the years 2010, 2011 and 2012 was $ 1.23, $ 2.29 and $ 1.83, respectively.
As of December 31, 2012, the total compensation cost related to options granted to employees, not yet recognized, amounted to $ 2,278. The cost is expected to be recognized over a weighted average period of 2.37 years.
Aggregate intrinsic value of options exercised in 2010, 2011 and 2012 amounted to $ 713, $ 580 and $ 555, respectively.
The options outstanding under the Company's Stock Option Plans as of December 31, 2012 have been separated into ranges of exercise price as follows:

Outstanding
   
Exercisable
 
           
Weighted
                   
           
average
   
Weighted
         
Weighted
 
Ranges of
         
remaining
   
average
         
average
 
exercise
   
Number of
   
contractual
   
exercise
   
Number of
   
exercise
 
price
   
options
   
life (years)
   
price
   
options
   
price
 
                                 
  2.30-3.51       50,000       0.52       3.27       50,000       3.27  
  4.04-4.38       997,168       3.39       4.23       300,000       4.38  
  5.12-5.99       299,336       3.12       5.80       33,334       5.61  
  6.04-6.93       229,004       2.68       6.65       145,670       6.62  
  7.11-7.85       354,792       3.12       7.47       121,667       7.49  
  9.14-9.98       393,334       4.59       9.80       43,334       9.98  
                                             
          2,323,634                       694,005          

Stock-based compensation was recorded in the following items

   
Year ended December 31,
 
   
2010
   
2011
   
2012
 
                   
Cost of sales
  $ 7     $ 10     $ 16  
Research and development
    145       108       221  
Selling and marketing
    151       78       168  
General and administrative
    458       987       651  
                         
Total Expenses
  $ 761     $ 1,183     $ 1,056